Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03898908
What this trial is testing

Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain

Who this might be right for
Metastatic MelanomaBrain Metastases
Grupo Español Multidisciplinar de Melanoma 48
Early research (Phase 1)Study completedNCT01698450
What this trial is testing

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Who this might be right for
Essential TremorDystoniaParkinson's Disease
University Children's Hospital, Zurich 10
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Not applicableStudy completedNCT00203008
What this trial is testing

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Who this might be right for
Parkinson's DiseaseMalignant Melanoma
Teva Branded Pharmaceutical Products R&D, Inc. 2,106
Not applicableStudy completedNCT00970788
What this trial is testing

A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma Patients

Who this might be right for
Advanced Brain Cancer
Massachusetts General Hospital 50
Not applicableWithdrawnNCT01736722
What this trial is testing

MRI-Guided LITT for Treatment Metastatic Brain Tumors

Who this might be right for
Brain Tumor
The Methodist Hospital Research Institute
Not applicableUnknownNCT03717766
What this trial is testing

Application of New Technologies in the Resection of Intracranial Tumors

Who this might be right for
Intracranial Neoplasm
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 100
Early research (Phase 1)Ended earlyNCT03539731
What this trial is testing

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Who this might be right for
Healthy SubjectIntracranial NeoplasmGlioblastoma
Guido A. Davidzon, MD, SM 27
Very early researchNot Yet RecruitingNCT06396481
What this trial is testing

Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma

Who this might be right for
GBMDIPG Brain TumorMedulloblastoma
Beijing Tiantan Hospital 25
Early research (Phase 1)Active Not RecruitingNCT02359565
What this trial is testing

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeLynch SyndromeMalignant Glioma+8 more
National Cancer Institute (NCI) 71
Early research (Phase 1)Not Yet RecruitingNCT07454668
What this trial is testing

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Who this might be right for
Breast CancerHER2-positive Breast CancerBrain Metastases+2 more
Baptist Health South Florida 20
Not applicableWithdrawnNCT06494046
What this trial is testing

Defining Musical Toxicity and Its Effect on Patient Well-being

Who this might be right for
Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT03873818
What this trial is testing

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT00047281
What this trial is testing

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT00977795
What this trial is testing

The Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors

Who this might be right for
Brain Neoplasms
Endeavor Health
Testing effectiveness (Phase 2)Study completedNCT00590954
What this trial is testing

Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Malignant GliomasCNSBrain Cancer+1 more
Memorial Sloan Kettering Cancer Center 32
Very early researchActive Not RecruitingNCT05076513
What this trial is testing

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+3 more
Nader Sanai 42
Not applicableStudy completedNCT06180460
What this trial is testing

CALM: Managing Distress in Malignant Brain Cancer

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+5 more
Virginia Commonwealth University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02374242
What this trial is testing

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Melanoma Institute Australia 76
Next Page